Converting visual acuity to utilities
References (21)
Utility approach to measuring healthrelated quality of life
J Chronic Dis
(1987)- et al.
Utility states and diabetic retinopathy
Am J Ophthalmol
(1999) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1
Arch Ophthalmol
(1985)Argon laser photocoagulation for neovascular maculopathy: three year results of a randomized clinical trial
Arch Ophthalmol
(1986)Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study
Arch Ophthalmol
(1979)Argon laser photocoagulation for macular edema in branch retinal vein occlusion
Am J Ophthalmol
(1984)Levels of evidence and interventional ophthalmology
Can J Ophthalmol
(1997)Incorporating patients' preferences into medical decisions
N Engl J Med
(1994)- et al.
Short Form 36 (SF36) Health Survey Questionnaire: normative data for adults of working age
BMJ
(1993) - et al.
The VF-14. An index of functional impairment in patients with cataract surgery
Arch Ophthalmol
(1994)
Cited by (104)
The cost-effectiveness of different visual acuity screening strategies in three European countries: A microsimulation study
2022, Preventive Medicine ReportsCitation Excerpt :Assumed costs of support of elderly with bilateral visual impairment due to persistent amblyopia (€1,000 per year) are included. One-way sensitivity analyses were performed for variation in attendance (80% and 100%), utility loss of treatment (0.01 for 1 year), utility loss for bilateral visual impairment (0.22) (Konig and Barry, 2004; Sharma et al., 2000), success of treatment of amblyopia (85% and 65% until age 5.5), screening test sensitivity and referral (10% lower and higher than base values), and costs (50% lower and higher). In addition we varied the utility loss for unilateral visual impairment.
Time Trade-off Utility Values in Noninfectious Uveitis
2019, American Journal of OphthalmologyHealth care stakeholder perceptions of vision loss
2019, Survey of OphthalmologySystematic methodological review of health state values in glaucoma cost-utility analyses
2024, European Journal of Health EconomicsComplement inhibitors for age-related macular degeneration
2023, Cochrane Database of Systematic Reviews
- *
The Cost-Effective Ocular Health Policy Unit, Hotel Dieu Hospital, Queen's University, Kingston, Ont.
- †
Evidence-Based Healthcare, Flourtown, Pa.
- ‡
The Retina Vascular Unit, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pa.
- §
The School of Public Health, Harvard University, Boston, Mass.